Scintimammography with 11 beta-methoxy-(17 alpha,20Z)-[I-123]iodovinylestradiol: A complementary role to Tc-99m-methoxyisobutyl isonitrile in the characterization of breast tumors
O. Nachar et al., Scintimammography with 11 beta-methoxy-(17 alpha,20Z)-[I-123]iodovinylestradiol: A complementary role to Tc-99m-methoxyisobutyl isonitrile in the characterization of breast tumors, J NUCL MED, 41(8), 2000, pp. 1324-1331
Citations number
36
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
The aim of this study was to investigate a possible relationship between Tc
-99m-methoxyisobutyl isonitrile (MIBI) uptake and the estrogen receptor (ER
) status of breast tumors as determined by 11 beta-methoxy-(17 alpha,20Z)-[
I-123]iodovinylestradiol (MIVE) scintimammography. Methods: Thirteen patien
ts referred for MIVE scintimammography after abnormal mammography or findin
g of a suspect mass on physical examination were injected intravenously wit
h MIVE. Planar images of the breasts and axillary region were taken with bo
th radiopharmaceuticals and compared with pathologic examination of the tum
or tissue and in vitro ER quantification. Results: The presence of cancerou
s tissue, as indicated by MIBI uptake, is a prerequisite for the accumulati
on of MIVE by the breast tumors. There was no statistically significant cor
relation between the MIBI and MIVE tumor uptake ratios. However, the latter
correlate well with the presence of ER, as determined by an in vitro assay
. Conclusion: MIVE scans add unique information concerning the tumor ER sta
tus in breast cancer patients, which could contribute to a better character
ization of the tumor and aid in the selection of the most appropriate treat
ment protocol.